Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an update.
Recordati S.p.A. has provided an update on its share buyback program, initiated on April 30, 2025, to support stock options and performance share plans for its management. The company reported purchasing 114,072 ordinary shares between August 4 and August 8, 2025, at a weighted average price of 50.3567 Euros per share, holding 1.951% of its share capital as of August 8, 2025. This move is part of Recordati’s strategic efforts to enhance shareholder value and align management incentives with company performance.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, originating from a family-run pharmacy in Northern Italy in the 1920s. The company offers therapeutic options in general and specialty medicine segments, as well as rare diseases, with integrated activities from clinical development to production, marketing, and licensing. Recordati operates in about 150 countries across EMEA, Americas, and APAC regions, employing over 4,580 people.
YTD Price Performance: -0.44%
Average Trading Volume: 273,668
Technical Sentiment Signal: Hold
Current Market Cap: €10.26B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.